Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
Completed
- Conditions
- Gastroesophageal Reflux Disease
- Registration Number
- NCT00768196
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
- GERD patients who have experienced heartburn or acid regurgitation during past 7 days
- GERD patients who have already undergone endoscopy before enrolment
Exclusion Criteria
- Involvement in the planning and conduct of the programme
- The person who took the medicine such as PPI or H2RA during the last 7 days
- Severe systemic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.
- Secondary Outcome Measures
Name Time Method The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.
Trial Locations
- Locations (1)
Research Site
🇰🇷Suwon, Kyungkido, Korea, Republic of